- Report
- February 2026
- 150 Pages
Global
From €5408EUR$5,950USD£4,650GBP
- Report
- September 2026
- 194 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- September 2026
- 375 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- August 2026
- 135 Pages
Global
From €4318EUR$4,750USD£3,712GBP
- Report
- April 2026
- 160 Pages
Global
From €3018EUR$3,320USD£2,595GBP
€3772EUR$4,150USD£3,243GBP
- Report
- March 2026
- 293 Pages
Global
From €3772EUR$4,150USD£3,243GBP
- Report
- April 2026
- 139 Pages
Global
From €2726EUR$2,999USD£2,344GBP
€3635EUR$3,999USD£3,125GBP
- Report
- January 2026
- 182 Pages
Global
From €4090EUR$4,500USD£3,517GBP
- Report
- September 2026
- 194 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- September 2026
- 181 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- September 2026
- 367 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- September 2026
- 378 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- August 2026
- 173 Pages
Global
From €3590EUR$3,950USD£3,087GBP
- Report
- August 2026
- 178 Pages
Global
From €3590EUR$3,950USD£3,087GBP
- Report
- August 2026
- 140 Pages
Global
From €3590EUR$3,950USD£3,087GBP
- Report
- July 2026
- 160 Pages
Global
From €3018EUR$3,320USD£2,595GBP
€3772EUR$4,150USD£3,243GBP
- Report
- April 2026
- 112 Pages
Global
From €3500EUR$4,125USD£3,115GBP

The Neurodiagnostics market is a subset of the Diagnostics industry, focusing on the diagnosis and treatment of neurological disorders. It includes a range of technologies and services, such as imaging, EEG, EMG, and evoked potentials, to diagnose and monitor neurological conditions. Neurodiagnostics also includes the use of biomarkers to detect and monitor neurological diseases.
The Neurodiagnostics market is driven by the increasing prevalence of neurological disorders, the development of new technologies, and the growing demand for personalized medicine. Additionally, the increasing focus on preventive healthcare and the rising awareness of neurological disorders are expected to drive the market.
Some companies in the Neurodiagnostics market include Philips Healthcare, Siemens Healthineers, GE Healthcare, Medtronic, and Natus Medical. Show Less Read more